BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37149114)

  • 1. Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs.
    Silvestrini AVP; Garcia Praça F; Leite MN; de Abreu Fantini MC; Frade MAC; Badra Bentley MVL
    Int J Pharm; 2023 Jun; 640():123019. PubMed ID: 37149114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation.
    Thapa RK; Yoo BK
    J Dermatolog Treat; 2014 Feb; 25(1):22-5. PubMed ID: 23210668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase.
    Depieri LV; Borgheti-Cardoso LN; Campos PM; Otaguiri KK; Vicentini FT; Lopes LB; Fonseca MJ; Bentley MV
    Eur J Pharm Biopharm; 2016 Aug; 105():50-8. PubMed ID: 27224855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles.
    Madheswaran T; Baskaran R; Yoo BK; Kesharwani P
    J Pharm Sci; 2017 Nov; 106(11):3385-3394. PubMed ID: 28652158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy.
    Singh N; Marwaha D; Gautam S; Rai N; Tiwari P; Sharma M; Shukla RP; Mugale MN; Kumar A; Mishra PR
    Biomacromolecules; 2023 Dec; 24(12):5780-5796. PubMed ID: 38006339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid crystalline nanodispersion functionalized with cell-penetrating peptides improves skin penetration and anti-inflammatory effect of lipoic acid after in vivo skin exposure to UVB radiation.
    Campos PM; Praça FG; Mussi SV; Figueiredo SA; Fantini MCA; Fonseca MJV; Torchilin VP; Bentley MVLB
    Drug Deliv Transl Res; 2020 Dec; 10(6):1810-1828. PubMed ID: 32803561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy.
    Suzuki IL; de Araujo MM; Bagnato VS; Bentley MVLB
    J Control Release; 2021 Oct; 338():316-329. PubMed ID: 34437914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyceryl monooleyl ether-based liquid crystalline nanoparticles as a transdermal delivery system of flurbiprofen: characterization and in vitro transport.
    Uchino T; Murata A; Miyazaki Y; Oka T; Kagawa Y
    Chem Pharm Bull (Tokyo); 2015; 63(5):334-40. PubMed ID: 25948327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
    Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
    J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis.
    Viegas JSR; Praça FG; Caron AL; Suzuki I; Silvestrini AVP; Medina WSG; Del Ciampo JO; Kravicz M; Bentley MVLB
    Drug Deliv Transl Res; 2020 Jun; 10(3):646-660. PubMed ID: 32060883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro.
    Wadhwa R; Paudel KR; Chin LH; Hon CM; Madheswaran T; Gupta G; Panneerselvam J; Lakshmi T; Singh SK; Gulati M; Dureja H; Hsu A; Mehta M; Anand K; Devkota HP; Chellian J; Chellappan DK; Hansbro PM; Dua K
    J Food Biochem; 2021 Jan; 45(1):e13572. PubMed ID: 33249629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis.
    Lee WR; Chou WL; Lin ZC; Sung CT; Lin CY; Fang JY
    J Control Release; 2022 Jul; 347():590-606. PubMed ID: 35623494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the drug permeation mechanism from flurbiprofen-loaded glyceryl monooleyl ether-based lyotropic liquid crystalline nanoparticles across the skin: Synchrotron X-ray diffraction and confocal laser scanning microscopy study.
    Uchino T; Kato S; Hatta I; Miyazaki Y; Suzuki T; Sasaki K; Kagawa Y
    Int J Pharm; 2019 Jan; 555():259-269. PubMed ID: 30447335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery.
    El-Gendy MA; Mansour M; El-Assal MIA; Ishak RAH; Mortada ND
    Int J Pharm; 2020 May; 582():119313. PubMed ID: 32283196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
    Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
    Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations.
    Mandal A; Kumbhojkar N; Reilly C; Dharamdasani V; Ukidve A; Ingber DE; Mitragotri S
    Sci Adv; 2020 Jul; 6(30):eabb6049. PubMed ID: 32832675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques.
    Marepally S; Boakye CH; Patel AR; Godugu C; Doddapaneni R; Desai PR; Singh M
    Nanomedicine (Lond); 2014 Jul; 9(14):2157-74. PubMed ID: 24593003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
    J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
    He C; Yin L; Song Y; Tang C; Yin C
    Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
    Pradhan M; Singh D; Singh MR
    Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.